Though central nervous system (CNS) actions of hepcidin in ALS have not been evaluated, in transgenic models of this disease serum hepcidin increase is accompanied by FPN downregulation in muscles [134]. The gene discussed is HAMP; the disease is amyotrophic lateral sclerosis.